Retatrutide peptide therapy is an experimental weight loss solution
GLP-1s and weight loss Well-established as weight-loss treatments, these medications work by stimulating receptors for the hormone glucagon-like peptide 1 (GLP-1) to suppress hunger
Use of artificial intelligence (AI)-assisted technology for manuscript preparation The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI
By David Prince, MD | Montefiore Medical Center Although new GLP-1 agonist weight loss drugs such as Ozempic, Wegovy, Trulicity, and Byetta are currently dominating the headlines, the majority of overweight Americans may not qualify for these medications due to limited availability and insurance plan restrictions
David Ludwig, an endocrinologist at Harvard and Boston Childrens Hospital, and a researcher whos been focusing on low-carb nutrition on metabolic health, and also Gary Taubes, an investigated journalist and author who spent decades investigating health, why we gain weight, nutrition
